Type I interferons inhibit the generation of tumor-associated macrophages

被引:0
|
作者
Lance U’Ren
Amanda Guth
Debra Kamstock
Steven Dow
机构
[1] Colorado State University,Department of Microbiology, Immunology, and Pathology
[2] Colorado State University,Department of Clinical Sciences
来源
Cancer Immunology, Immunotherapy | 2010年 / 59卷
关键词
Cytokine; CSF-1; Cancer; Angiogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
Tumor-associated macrophages (TAM) are very abundant in tumors and are thought to play a major role in promoting tumor growth. The generation of TAM is positively regulated by several cytokines, including colony stimulating factor-1 (CSF-1) and monocyte chemoattractant protein-1 (CCL2). However, endogenous factors that suppress the generation of TAM within tumors have not been previously identified. An earlier study showed that endogenously produced type I interferons (IFN) suppressed tumor growth via their effects on hematopoietic cells rather than through direct effects on tumor cells. Therefore, we used mouse tumor models to investigate the effects of endogenously produced type I IFNs on the generation of TAM. We found using immunohistochemistry and flow cytometry that TAM density was significantly increased in tumors of mice lacking the type I IFN receptor (IFN-α/βR−/− mice) compared to wild type mice. Moreover, the increase in TAM density was associated with a significant increase in tumor growth rate and angiogenesis. The phenotype of TAM was similar in IFN-α/βR−/− mice and wild type mice and tumors in both mice produced similar amounts of CSF-1 and CCL2. However, in vitro assays indicated that low concentrations of type I IFNs significantly inhibited the generation of bone marrow macrophages in response to CSF-1. These findings indicate that endogenously produced type I IFNs suppress the generation of TAM, which may in turn account for inhibition of tumor growth and angiogenesis.
引用
收藏
页码:587 / 598
页数:11
相关论文
共 50 条
  • [1] Type I interferons inhibit the generation of tumor-associated macrophages
    U'Ren, Lance
    Guth, Amanda
    Kamstock, Debra
    Dow, Steven
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (04) : 587 - 598
  • [2] The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils
    Pylaeva, Ekaterina
    Lang, Stephan
    Jablonska, Jadwiga
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [4] Arming tumor-associated macrophages to inhibit cancer progression
    Reddy, Joshua P.
    Yu, Ziqi
    Shepard, Ryan M.
    Von Schalscha, Tami
    McCormack, Stephen J.
    Weis, Sara M.
    Cheresh, David A.
    Wettersten, Hiromi I.
    CANCER RESEARCH, 2024, 84 (06)
  • [5] Tumor-associated macrophages
    Cassetta, Luca
    Pollard, Jeffrey W.
    CURRENT BIOLOGY, 2020, 30 (06) : R246 - R248
  • [6] TUMOR-ASSOCIATED MACROPHAGES
    MANTOVANI, A
    CURRENT OPINION IN IMMUNOLOGY, 1990, 2 (05) : 689 - 692
  • [7] Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth
    Ramesh, Anujan
    Malik, Vaishali
    Brouillard, Anthony
    Kulkarni, Ashish
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2022, 110 (08) : 1448 - 1459
  • [8] Tumor-Associated Macrophages in Tumor Immunity
    Pan, Yueyun
    Yu, Yinda
    Wang, Xiaojian
    Zhang, Ting
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] Tumor promotion by tumor-associated macrophages
    Porta, Chiara
    Kumar, Biswas Subhra
    Larghi, Paola
    Rubino, Luca
    Mancino, Alessandra
    Sica, Antonio
    ADVANCES IN MOLECULAR ONCOLOGY, 2007, 604 : 67 - 86
  • [10] AUGMENTED TUMOR-ASSOCIATED ANTIGEN EXPRESSION BY INTERFERONS
    BORDEN, EC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (03) : 148 - 149